About: Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2006

Attributes	Values
rdf:type	Item
description	article scientifique publié en 2006 (fr) наукова стаття, опублікована в листопаді 2005 (uk) im November 2005 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2006 (ast) scientific article published on 01 April 2006 (en)
publication date	wds:Q61758658-D28B9151-B7D1-4D87-AA95-FF6949C2664B
publication date	2006-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61758658-59F4BC39-D401-4A18-9206-8CC5FA6FDD0A
language of work or name	English
author name string	wds:Q61758658-0312AD88-B85C-4E20-BAD1-649810FEA8FE wds:Q61758658-3B5E8CAE-F0FB-41CC-896E-7D361F681DB1 wds:Q61758658-532BA782-51B7-43F3-9E16-F4F5482DC7A7 wds:Q61758658-99A56D31-F307-4BF5-A303-4BDF3E2A9AF2 wds:Q61758658-A7944156-E767-4152-B012-A1015F521164 wds:Q61758658-DAE586A9-73FB-4A13-BD91-42843D19E942 wds:Q61758658-F1CDC522-A65C-4B5D-8DA8-565CDBC257F0 wds:Q61758658-F4D48512-7789-459E-98F0-624DE0F151B1
author name string	Zhiyong Yang Jenny M Lippitt Malcolm W R Reed Robert E Coleman Clair A Evans Sabapathy P Balasubramanian Helen L Neville-Webbe Julia K Woodward
rdfs:label	Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis? (en)
skos:prefLabel	Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis? (en)
name	Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis? (en)
author	wds:Q61758658-06267FCD-BE00-43EF-A020-433AD0F0502B wds:Q61758658-81CFF7CD-B0F2-458E-9C43-A47D912737E5 wds:Q61758658-F02500DD-0BC8-487F-9B73-F1DE8F20A215
author	Simon S. Cross Nicola J. Brown Ingunn Holen
title	wds:Q61758658-8AD4C0A3-A1C9-43D0-A6BA-F5C111F67D0B
title	Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis? (en)
page(s)	wds:Q61758658-C614767F-D5EE-46D8-B142-A28DA98B8DCF
page(s)	1901-1908
instance of	wds:Q61758658-E17815BB-C0D2-469D-BD11-EFA98011DE73
instance of	scholarly article
main subject	wds:Q61758658-858998AF-C70B-4EC8-B388-57BCBDA2DF51 wds:Q61758658-DFA5096E-A81E-4375-A187-8372AADFEBAA wds:Q61758658-EB9E2AC4-7AB2-4857-9A36-107F9F2A6317
main subject	phenotype angiogenesis tumor angiogenesis
PubMed ID	wds:Q61758658-439C0EB0-2959-4E4F-9FC5-6E5DF3FEE830
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16287088
PubMed ID	16287088
published in	wds:Q61758658-814DCF48-CFE9-4B3C-A307-4BE5EC00C44C
published in	International Journal of Cancer
issue	wds:Q61758658-B792025A-1619-4CDE-AA55-908155264A1E
volume	wds:Q61758658-AE58733E-46B6-4143-8441-EC202104B2A3
issue	8
volume	118
DOI	wds:Q61758658-263ED9D3-CA17-40CD-B3A3-FEE743E4EA86
DOI	http://dx.doi.org/10.1002/IJC.21606
DOI	10.1002/IJC.21606
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61758658
is cites work of	Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles Biomaterials that regulate growth factor activity via bioinspired interactions Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels Targeting the tumor microenvironment: focus on angiogenesis Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications Osteoprotegerin in breast cancer: beyond bone remodeling Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis Screening for Multiple Autoantibodies in Plasma of Patients with Breast Cancer. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene Osteoprotegerin rich tumor microenvironment: implications in breast cancer Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells Significant Association between OPG/TNFRSF11B Variant and Common Complex Ischemic Stroke. Immunoregulation of bone remodelling Osteoprotegerin (OPG) Promotes Recruitment of Endothelial Progenitor Cells (EPCs) via CXCR4 Signaling Pathway to Improve Bone Defect Repair Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27 450 Participants RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells Transactivation of human osteoprotegerin promoter by GATA-3 Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. Osteoprotegerin Induces CD34+ Differentiation in Endothelial Progenitor Cells
is cites work of	wds:Q34555532-C8894CEE-CBF3-4486-A9AD-CDAD03859368 wds:Q47434341-ACD589CE-29E7-4B71-842B-16262E0E52A1 wds:Q90442956-8250AF2E-2B2C-461D-ADC8-201FE7FE80BD wds:Q28076305-0A5D604D-8E8B-4C5B-A481-88E4DAD58D21 wds:Q37418199-E14E7CF5-3751-41BE-807F-B15BD35D7523 wds:Q92217808-E649C1A0-5442-4BA8-9213-653F26D74A96

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software